Latest filing published 06 Feb 2025 for Revance Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Julian S. Gangolli: trading record in brief
Julian S. Gangolli, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Allergan Inc, GW Pharmaceuticals PLC and Revance Therapeutics, Inc. The record holds 62 filings, for trades running from 28 November 2011 to 6 February 2025.
On the market, this insider has only sold: 17 sales, €22.6M in total. The rest of the record consists of 17 share grants and 11 option exercises.
On 6 February 2025 came the latest disclosure, a transaction in Revance Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Julian S. Gangolli
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,000 sharesCommon StockSEC:0000950170-25-015688:1
- 30,106 shares@ US$3.65100.0% of flowCommon StockSEC:0000950170-25-015688:0
- 10,930 shares@ US$163.7147.9% of flowCommon StockSEC:0001532023-24-000008:1
- 7,090 shares@ US$164.3431.2% of flowCommon StockSEC:0001532023-24-000008:2
- 1,980 shares@ US$165.768.8% of flowCommon StockSEC:0001532023-24-000008:3
- 20,000 shares@ US$22.75100.0% of flowCommon StockSEC:0001532023-24-000008:0
- 15,000 shares0Common StockSEC:0001479290-24-000086:0
- 3,534 shares0Common StockSEC:0001479290-23-000064:0
- 6,059 shares0Common StockSEC:0001479290-22-000061:0
- 4,013 shares0Common StockSEC:0001479290-21-000108:0
- 6,000 shares0Common StockSEC:0001479290-20-000064:0
- 403,804 shares0Ordinary SharesSEC:0000899243-19-013509:0
- 75,369 shares@ US$10.616.9% of flowOrdinary SharesSEC:0000899243-19-013509:1
- 192,755 shares@ US$3.726.2% of flowOrdinary SharesSEC:0000899243-19-013509:2
- 117,876 shares@ US$14.6314.9% of flowOrdinary SharesSEC:0000899243-19-013509:3
- 81,156 shares@ US$14.7010.3% of flowOrdinary SharesSEC:0000899243-19-013509:4
- 65,268 shares@ US$14.808.4% of flowOrdinary SharesSEC:0000899243-19-013509:5
- 208,260 shares@ US$14.8826.8% of flowOrdinary SharesSEC:0000899243-19-013509:6
- 145,164 shares@ US$14.9618.8% of flowOrdinary SharesSEC:0000899243-19-013509:7
- 12,048 shares@ US$15.031.6% of flowOrdinary SharesSEC:0000899243-19-013509:8
- 31,368 shares@ US$15.124.1% of flowOrdinary SharesSEC:0000899243-19-013509:9
- 10,788 shares@ US$15.191.4% of flowOrdinary SharesSEC:0000899243-19-013509:10
- 4,500 shares0Common StockSEC:0001479290-19-000056:0
- 11,256 shares0Ordinary SharesSEC:0000899243-19-005266:0
- 5,952 shares@ US$12.450.6% of flowOrdinary SharesSEC:0000899243-19-005266:1
25 of 62 declarations
